BACKGROUND: Obesity is a known risk factor for wound complications; however, unlike elective upper extremity procedures, where obesity can be modified preoperatively, excision of soft tissue sarcomas (STSs) is not elective, and as such, obesity cannot be modified. There is a paucity of data concerning the impact of obesity on wound healing in upper extremity sarcoma surgery. METHODS: A total of 261 (159 males and 102 females) patients with a STS of the upper extremity from 2006-2014 were reviewed. The mean age and body mass index (BMI) were 56 (18-97) years and 26.6 (15.4-40.8) kg/m2, respectively. Sixty-nine patients (26%) were classified as obese (BMI ⩾30 kg/m2): class I (obese, BMI = 30-34.9 kg/m2; n = 48, 18%), class II (severely obese, BMI = 35.0-39.9 kg/m2; n = 16, 6%), and class III (morbidly obese, BMI ≥ 40 kg/m2; n = 5, 2%). Functional outcomes were also compared between obese and nonobese patients using the Musculoskeletal Tumor Society (MSTS) 1993 rating system and Toronto Extremity Salvage Scores (TESS). RESULTS: Forty-nine patients (19%) sustained a wound dehiscence, delayed healing, or infection. Class III obesity increased the risk of wound complications (hazard ratio [HR] = 8.19, 95% confidence interval [CI] = 1.96-22.96, P < .001) and infection (HR = 10.09, 95% CI = 1.60-34.83, P = .01). There was no difference in the mean TESS (93 vs 90, P = .13) or MSTS93 (95 vs 93, P = .39) between obese and nonobese patients. CONCLUSIONS: The results of this study indicate morbid obesity significantly increased the risk of a postoperative wound complication and infection. However, following upper extremity limb salvage surgery, obese patients should expect to have excellent functional outcome.
BACKGROUND:Obesity is a known risk factor for wound complications; however, unlike elective upper extremity procedures, where obesity can be modified preoperatively, excision of soft tissue sarcomas (STSs) is not elective, and as such, obesity cannot be modified. There is a paucity of data concerning the impact of obesity on wound healing in upper extremity sarcoma surgery. METHODS: A total of 261 (159 males and 102 females) patients with a STS of the upper extremity from 2006-2014 were reviewed. The mean age and body mass index (BMI) were 56 (18-97) years and 26.6 (15.4-40.8) kg/m2, respectively. Sixty-nine patients (26%) were classified as obese (BMI ⩾30 kg/m2): class I (obese, BMI = 30-34.9 kg/m2; n = 48, 18%), class II (severely obese, BMI = 35.0-39.9 kg/m2; n = 16, 6%), and class III (morbidly obese, BMI ≥ 40 kg/m2; n = 5, 2%). Functional outcomes were also compared between obese and nonobese patients using the Musculoskeletal Tumor Society (MSTS) 1993 rating system and Toronto Extremity Salvage Scores (TESS). RESULTS: Forty-nine patients (19%) sustained a wound dehiscence, delayed healing, or infection. Class III obesity increased the risk of wound complications (hazard ratio [HR] = 8.19, 95% confidence interval [CI] = 1.96-22.96, P < .001) and infection (HR = 10.09, 95% CI = 1.60-34.83, P = .01). There was no difference in the mean TESS (93 vs 90, P = .13) or MSTS93 (95 vs 93, P = .39) between obese and nonobese patients. CONCLUSIONS: The results of this study indicate morbid obesity significantly increased the risk of a postoperative wound complication and infection. However, following upper extremity limb salvage surgery, obesepatients should expect to have excellent functional outcome.
Authors: Eric R Wagner; Matthew T Houdek; Cathy Schleck; William S Harmsen; Joaquin Sanchez-Sotelo; Robert Cofield; John W Sperling; Bassem T Elhassan Journal: J Bone Joint Surg Am Date: 2017-06-07 Impact factor: 5.284
Authors: Vignesh K Alamanda; David C Moore; Yanna Song; Herbert S Schwartz; Ginger E Holt Journal: Clin Orthop Relat Res Date: 2014-06-06 Impact factor: 4.176
Authors: Christopher P Cannon; Matthew T Ballo; Gunar K Zagars; Attiqa N Mirza; Patrick P Lin; Valerae O Lewis; Alan W Yasko; Robert S Benjamin; Peter W T Pisters Journal: Cancer Date: 2006-11-15 Impact factor: 6.860
Authors: Jennifer F Tseng; Matthew T Ballo; Howard N Langstein; Jeffrey D Wayne; Janice N Cormier; Kelly K Hunt; Barry W Feig; Alan W Yasko; Valerae O Lewis; Patrick P Lin; Christopher P Cannon; Gunar K Zagars; Raphael E Pollock; Peter W T Pisters Journal: Ann Surg Oncol Date: 2006-09-03 Impact factor: 5.344
Authors: J Slump; P C Ferguson; J S Wunder; A M Griffin; H J Hoekstra; X Liu; S O P Hofer; A C O'Neill Journal: Eur J Surg Oncol Date: 2017-02-08 Impact factor: 4.424
Authors: Kristen M Davidge; Jay Wunder; George Tomlinson; Rebecca Wong; Joan Lipa; Aileen M Davis Journal: Ann Surg Oncol Date: 2010-01-27 Impact factor: 5.344
Authors: Fausto Petrelli; Alessio Cortellini; Alice Indini; Gianluca Tomasello; Michele Ghidini; Olga Nigro; Massimiliano Salati; Lorenzo Dottorini; Alessandro Iaculli; Antonio Varricchio; Valentina Rampulla; Sandro Barni; Mary Cabiddu; Antonio Bossi; Antonio Ghidini; Alberto Zaniboni Journal: JAMA Netw Open Date: 2021-03-01